|
|
||||||||
From the Department of Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina 27710
Abstract
Cell-mediated immunity to SV40-transformed C3H and C3H·SW cell lines was measured by using both 51Cr and 125IUdR release assays. Killing by cytotoxic cells generated on in vitro sensitization of immune spleen cells with syngeneic SV40 cells by either assay is specific for syngeneic SV40 transformants. Cytolysis mediated by in vitro sensitized cells is ablated by treatment of the effector cells with anti-
serum and complement. Intraperitoneal immunization with syngeneic SV40 cells yields two distinct killer-cell populations in the peritoneal exudate when assayed by 125IUdR release. The first, nylon wool nonadherent and sensitive to anti-
and complement, is indistinguishable from the killers generated in vitro. The second population, present in larger numbers and more efficient on a per-cell basis in killing of SV40 targets than the first, is nylon adherent and is not removed by treatment with anti-
and complement. This second population will kill any SV40 transformed target, whether syngeneic or allogeneic. The possible roles of T cell and non-T cell effectors in rejection of syngeneic SV40 tumors are discussed.
Footnotes
1 This work was supported by Grant CA-16802 from the National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
This article has been cited by other articles:
![]() |
O. Utermohlen, C. Schulze-Garg, G. Warnecke, R. Gugel, J. Lohler, and W. Deppert Simian Virus 40 Large-T-Antigen-Specific Rejection of mKSA Tumor Cells in BALB/c Mice Is Critically Dependent on both Strictly Tumor-Associated, Tumor-Specific CD8+ Cytotoxic T Lymphocytes and CD4+ T Helper Cells J. Virol., November 15, 2001; 75(22): 10593 - 10602. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Strayer and D. S. Strayer SV40 As an Effective Gene Transfer Vector in Vivo J. Biol. Chem., October 4, 1996; 271(40): 24741 - 24746. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |